Cost of Genetic Cancer Risk Testing in Saudi Arabia
A comprehensive Genetic Cancer Risk Assessment in Saudi Arabia at King Faisal Specialist Hospital & Research Centre is set at a fixed rate of USD 1,600. This standard pricing structure includes complete pre-test counseling, sample collection, DNA sequencing analysis, and formal post-test results discussion without hidden laboratory processing fees. Below is a comparative overview of international pricing estimates for germline BRCA and Lynch syndrome testing panels.
| Location / Diagnostic Provider | Price in USD | Comparative Value Note |
|---|---|---|
| Saudi Arabia (KFSHRC) | $1,600 USD | All-inclusive standard outpatient bundle |
| Canada | $2,500 – $4,000 USD | Out-of-pocket non-resident laboratory fee structures |
| United States | $3,000 – $5,500 USD | Variable physician, genetic counseling, and panel charges |
| Western Europe | $2,200 – $3,800 USD | Private tertiary laboratory testing estimates |
Note: Proposed pricing is fixed at USD 1,600 for the defined BRCA and Lynch syndrome targeted package. Additional diagnostic investigations or expanded multigene sequencing outside the initial request are subject to separate billing.
What Is Covered in Your Genetic Cancer Risk Testing Package?
The USD 1,600 outpatient testing pathway is structured to manage every essential component of your germline risk evaluation. The comprehensive program covers the following services:
-
Pre-test genetic counseling and formal risk assessment.
-
Comprehensive personal and family cancer history review.
-
Germline hereditary cancer testing targeting BRCA1, BRCA2, and primary Lynch syndrome genes.
-
Sample collection procedures (peripheral blood or saliva).
-
Laboratory extraction, DNA processing, and high-throughput sequencing analysis.
-
Targeted variant interpretation and clinical classification.
-
Official diagnostic laboratory report generation.
-
Post-test genetic counseling and detailed results explanation.
-
Routine referral advice for personalized screening protocols and management next steps.
What Is Excluded from the Package Offer?
Clinical services, procedures, and secondary diagnostic tests falling outside the targeted BRCA and Lynch syndrome workflow are billed independently and are not covered under the USD 1,600 baseline package:
-
Biopsy or surgical tissue-acquisition procedures.
-
Oncology or specialist physician consultations unless explicitly stated in the package.
-
Expanded multigene hereditary cancer panels beyond the ordered test scope.
-
Trio or family comparator genetic testing.
-
Cascade family screening testing for relatives.
-
Confirmatory follow-up testing or variant segregation studies.
-
Preventive surveillance screenings, diagnostic imaging, or prophylactic surgical interventions.
-
Downstream medical, surgical, or therapeutic cancer treatments.
-
Advanced molecular tumor profiling or somatic testing on solid tumor tissue.
Understanding BRCA and Lynch Syndrome Genetic Testing
Germline Inherited Cancer Testing in Saudi Arabia evaluates specific genes linked to hereditary cancer syndromes. Mutations in the BRCA1 and BRCA2 genes significantly increase susceptibility to breast, ovarian, prostate, and pancreatic malignancies. Similarly, Lynch syndrome—caused by alterations in mismatch repair genes such as MLH1, MSH2, MSH6, and PMS2—is associated with an elevated risk of colorectal, endometrial, gastric, and ovarian cancers.
During the outpatient process at King Faisal Specialist Hospital & Research Centre, DNA is extracted from a standard blood or saliva sample. Advanced Next-Generation Sequencing (NGS) and bioinformatic pipelines process the coding regions to detect single nucleotide variants, insertions, or deletions. Identifying these pathogenic variations provides actionable information to structure enhanced screening frequencies, early detection protocols, and risk-reducing strategies.
Why Choose King Faisal Specialist Hospital & Research Centre?
Selecting an established institution for genetic evaluations ensures high standards of scientific precision and medical oversight. King Faisal Specialist Hospital & Research Centre provides structured diagnostic services based on key institutional capabilities:
-
Tertiary Diagnostic Infrastructure: Specialized molecular diagnostic laboratories utilizing modern high-throughput sequencing technology.
-
Integrated Genetic Services: Dedicated genetic counselors and clinical geneticists working within standardized diagnostic frameworks.
-
Standardized Clinical Pipelines: Rigorous bioinformatic filtering and variant classification aligned with international laboratory guidelines.
-
Clear Patient Pathways: Outpatient workflow designed for efficient single-day evaluation, sample collection, and scheduled post-test review.
-
International Service Framework: Administrative infrastructure equipped to assist regional and international self-referrals.
Your Outpatient Care Journey: Sample Testing Timeline
The clinical timeline for genetic cancer risk assessment is completed in a single 1-day outpatient visit, followed by scheduled post-test review once laboratory sequencing is complete:
-
Pre-Test Phase: Outpatient Visit Day 1 (Morning)
-
Outpatient registration and initial clinical genetic intake.
-
Pre-test genetic counseling session, pedigree mapping, and personal/family history review.
-
-
Sample Collection Phase: Outpatient Visit Day 1 (Mid-Day)
-
Standard peripheral blood draw or saliva sample collection under clinical supervision.
-
Sample logging, verification, and transfer to the molecular genetics laboratory for DNA extraction.
-
-
Analysis & Reporting Phase: Post-Visit (Laboratory Processing)
-
High-throughput DNA sequencing, variant alignment, and bioinformatic classification.
-
Official diagnostic laboratory report generation and verification by molecular specialists.
-
Post-test genetic counseling consultation (in-person or telehealth) to discuss results and management advice.
-
Expected Results from Genetic Cancer Risk Testing
Patients undergoing germline BRCA and Lynch syndrome testing receive a definitive laboratory report detailing variant classifications based on established ACMG guidelines (Positive/Pathogenic, Negative/Benign, or Variant of Uncertain Significance). Identifying a pathogenic variant allows healthcare providers to implement targeted screening protocols—such as earlier mammograms, breast MRIs, colonoscopies, or risk-reducing discussions—enabling proactive management of hereditary risk.
Advantages of Receiving Healthcare Care in Saudi Arabia
-
Advanced Medical Centers: Direct access to major healthcare organizations such as King Faisal Specialist Hospital & Research Centre.
-
Specialized Clinical Staff: Medical care delivered by experienced geneticists, molecular pathologists, and trained counselors.
-
Defined Financial Parameters: Fixed-rate packaging offering predictable expenses for standard diagnostic testing.
-
Regional Connectivity: Modern transportation and travel infrastructure for patients visiting Riyadh from regional or international destinations.
Frequently Asked Questions
1. What is covered in the USD 1,600 genetic testing package at KFSHRC?
The package covers pre-test risk assessment, personal/family history review, germline testing for BRCA1, BRCA2, and Lynch syndrome genes, sample collection, DNA extraction, sequencing analysis, standard laboratory report, post-test counseling, and routine screening referral advice.
2. How long is the hospital stay required for this testing package?
This is an outpatient package requiring a 1-day hospital stay for initial evaluation, pre-test counseling, and sample collection.
3. What sample type is collected for the genetic test?
Germline DNA is extracted from a standard peripheral blood sample or saliva specimen collected during your outpatient visit.
4. Does the test analyze somatic tumor tissue?
No. This package focuses exclusively on germline DNA to evaluate inherited cancer risk and does not include molecular profiling of solid tumor tissue.
5. What genes are included in the testing panel?
The panel targets the BRCA1 and BRCA2 genes associated with hereditary breast and ovarian cancer, along with primary Lynch syndrome mismatch repair genes.
6. What services are excluded from the package price?
Exclusions include tissue biopsies, un-packaged specialist consultations, expanded multigene panels, family comparator testing, cascade relative testing, follow-up imaging, surgery, and downstream treatments.
7. Is genetic counseling provided after results are ready?
Yes. Post-test genetic counseling is included in the package to explain your laboratory report and discuss recommended risk-management next steps.
8. Does the package cover testing for family members?
No. Cascade family testing and trio/comparator testing for relatives are excluded from the baseline individual package.
9. What happens if a Variant of Uncertain Significance (VUS) is found?
Your genetic counselor will explain the nature of the VUS during the post-test consultation and provide standard clinical surveillance recommendations based on current medical guidelines.
10. How can international patients arrange this testing package?
Patients can submit their personal and family medical histories through PlacidWay to coordinate record review and schedule their outpatient visit at KFSHRC in Riyadh.
Take the Next Step in Your Preventive Healthcare Journey
Understanding inherited cancer risks enables clear medical decision-making and proactive health management. Through PlacidWay, you can connect with King Faisal Specialist Hospital & Research Centre to review your candidacy for this specialized Inherited Cancer Testing in Saudi Arabia package.
-
Direct service coordination with genetic specialists at King Faisal Specialist Hospital & Research Centre.
-
Transparent itemized package guidelines covering pre-test assessment, testing, and post-test counseling inclusions.
-
Secure transmission of personal and family medical histories for preliminary evaluation.
-
Administrative assistance for international and regional healthcare scheduling.
Request your detailed medical quote today to receive formal evaluation and package details for your genetic testing procedure.
Get a Free Quote-Package-in-Saudi-Arabia-at-KFSHRC-Thumbnail.jpg)
-Package-in-Saudi-Arabia-at-KFSHRC-Thumbnail.jpg)
-Package-in-Saudi-Arabia-at-KFSHRC-Thumbnail.jpg)
.png)
Share this listing